Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Tambasco, Mauro ^a,b   Eliasziw, Misha ^a   Magliocco, Anthony M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PANCYTOKERATIN; TAMOXIFEN; UNCLASSIFIED DRUG; KERATIN;

ADULT; AGED; ARTICLE; BREAST EPITHELIUM; CANCER GRADING; CANCER INVASION; CANCER MORPHOLOGY; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; FRACTAL ANALYSIS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TISSUE MICROARRAY; VALIDATION STUDY; BREAST TUMOR; EPITHELIUM; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EPITHELIUM; FEMALE; FRACTALS; HUMANS; KAPLAN-MEIER ESTIMATE; KERATINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 78650650448     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-140     Document Type: Article

References (24)

1. Lonning PE, Knappskog S, Staalesen V, Chrisanthar R, Lillehaug JR. Breast cancer prognostication and prediction in the postgenomic era. Ann Oncol 2007, 18:1293-1306. 10.1093/annonc/mdm013, 17317675.
2. Cianfrocca M, Gradishar WJ. Controversies in the therapy of early stage breast cancer. Oncologist 2005, 10:766-779. 10.1634/theoncologist.10-10-766, 16314287.
3. Mori I, Yang Q, Kakudo K. Predictive and prognostic markers for invasive breast cancer. Pathol Int 2002, 52:186-194. 10.1046/j.1440-1827.2002.01335.x, 11972862.
4. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004, 9:606-616. 10.1634/theoncologist.9-6-606, 15561805.
5. Mirza AN, Mirza NQ, Vlastos G, Singletary SE. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002, 235:10-26. 10.1097/00000658-200201000-00003, 1422391, 11753038.
6. Elledge RM, McGuire WL. Prognostic factors and therapeutic decisions in axillary node-negative breast cancer. Annu Rev Med 1993, 44:201-210. 10.1146/annurev.me.44.020193.001221, 8476242.
7. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998, 352:930-942. 10.1016/S0140-6736(98)03301-7, 9752815.
8. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998, 351:1451-1467. 10.1016/S0140-6736(97)11423-4, 9605801.
9. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x, 1757079.
10. Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 1991, 68:2142-2149. 10.1002/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D, 1913453.
11. Saez RA, McGuire WL, Clark GM. Prognostic factors in breast cancer. Semin Surg Oncol 1989, 5:102-110. 10.1002/ssu.2980050206, 2657970.
12. Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, et al. Breast carcinoma malignancy grading by Bloom-Richardson system vs. proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 2005, 18:1067-1078. 10.1038/modpathol.3800388, 15920556.
13. Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, et al. Histological grading of breast carcinoma: a study of interobserver agreement. Hum Pathol 1995, 26:873-879. 10.1016/0046-8177(95)90010-1, 7635449.
14. Chowdhury N, Pai MR, Lobo FD, Kini H, Varghese R. Interobserver variation in breast cancer grading: a statistical modeling approach. Anal Quant Cytol Histol 2006, 28:213-218.
15. Rizki A, Bissell MJ. Homeostasis in the breast: it takes a village. Cancer Cell 2004, 6:1-2. 10.1016/j.ccr.2004.06.019, 15261134.
16. Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nat Med 1998, 4:882-885. 10.1038/nm0898-882, 9701230.
17. Baish JW, Jain RK. Cancer, angiogenesis and fractals. Nat Med 1998, 4:984. 10.1038/1952, 9734370.
18. Tambasco M, Costello BM, Kouznetsov A, Yau A, Magliocco AM. Quantifying the architectural complexity of microscopic images of histology specimens. Micron 2009, 40:486-494. 10.1016/j.micron.2008.12.004, 19171487.
19. Peitgen H, Jurgens H, Saupe D. Chaos and Fractals: New Frontiers of Science 2004, New York: Springer-Verlag, 2.
20. Dixon V, Tambasco M. Effects of image resolution and noise on estimating the fractal dimension of tissue specimens. Anal Quant Cytol Histol 2010, 32:269-279.
21. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods 1998, Duxbury Press, 3.
22. Tambasco M, Magliocco AM. Relationship between tumor grade and computed architectural complexity in breast cancer specimens. Hum Pathol 2008, 39:740-746. 10.1016/j.humpath.2007.10.001, 18439940.
23. Baish JW, Jain KJ. Fractals and cancer. Cancer Res 2000, 60:3683-3688.
24. Cross SS. Fractals in pathology. Journal of Pathology 1997, 182:1-8. 10.1002/(SICI)1096-9896(199705)182:1<1::AID-PATH808>3.0.CO;2-B, 9227334.